Rheumatology Providers, FDA Leaders Discuss Biosimilar Policy Challenges and Opportunities at National Policy Briefing WASHINGTON, June 20, 2016 (GLOBE NEWSWIRE) -- Experts from the American College of Rheumatology (ACR), Food and Drug Administration (FDA), and other leading national healthcare groups spoke about the...